The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis - PubMed (original) (raw)
The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis
H J Müllerèberhard et al. J Exp Med. 1966.
Abstract
During immune hemolysis by human complement, C'3 (beta(1C)-globulin) becomes physically attached to the erythrocyte membrane. Binding of C'3 was found to be mediated by cell-bound, activated C'2 and to have the characteristics of an enzymatic reaction. A single C'4,2a site on the cell surface effected the binding of several hundred molecules of C'3 if the latter was provided in excess. The accumulation of hemolytically inactive, physicochemically altered C'3 in the fluid phase was found to be an inherent feature of the process of C'3 binding. It is postulated that C'4,2a activates C'3 for its subsequent reaction with cell membrane receptors. Antierythrocyte antibody did not play an essential role in C'3 uptake; C'3 could be bound to erythrocyte-C'4,2a complexes which were entirely devoid of antibody. Cell-bound C'3 proved hemolytically active, the degree of hemolysis being proportional to the number of C'3 molecules per cell. Binding of a large number of C'3 molecules per cell was found to be a prerequisite for the production of the immune adherence phenomenon and for immune hemolysis.
Similar articles
- THE ROLE OF THE COMPONENTS OF COMPLEMENT IN SPECIFIC IMMUNE FIXATION.
Pillemer L, Seifter S, Ecker EE. Pillemer L, et al. J Exp Med. 1942 Apr 1;75(4):421-35. doi: 10.1084/jem.75.4.421. J Exp Med. 1942. PMID: 19871194 Free PMC article. - FUNCTION OF COMPONENTS OF COMPLEMENT IN IMMUNE HEMOLYSIS.
Pillemer L, Seifter S, Chu F, Ecker EE. Pillemer L, et al. J Exp Med. 1942 Jul 1;76(1):93-101. doi: 10.1084/jem.76.1.93. J Exp Med. 1942. PMID: 19871223 Free PMC article. - The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.
Polley MJ, Müller-Eberhard HJ. Polley MJ, et al. J Exp Med. 1968 Sep 1;128(3):533-51. doi: 10.1084/jem.128.3.533. J Exp Med. 1968. PMID: 5666963 Free PMC article. - Human complementary component C'3: an appraisal.
Seth PK, Seth S. Seth PK, et al. Hum Genet. 1976 Aug 30;33(3):201-11. doi: 10.1007/BF00286844. Hum Genet. 1976. PMID: 786850 Review.
Cited by
- Novel Monoclonal Antibodies Against Mouse C1q: Characterisation and Development of a Quantitative ELISA for Mouse C1q.
Byrne RAJ, Torvell M, Daskoulidou N, Fathalla D, Kokkali E, Carpanini SM, Morgan BP. Byrne RAJ, et al. Mol Neurobiol. 2021 Sep;58(9):4323-4336. doi: 10.1007/s12035-021-02419-5. Epub 2021 May 18. Mol Neurobiol. 2021. PMID: 34002346 Free PMC article. - Anticomplementary activity of tuberculin: relationship to platelet aggregation and lytic response.
Rourke FJ, Fan SS, Wilder MS. Rourke FJ, et al. Infect Immun. 1979 Jan;23(1):160-7. doi: 10.1128/iai.23.1.160-167.1979. Infect Immun. 1979. PMID: 106002 Free PMC article. - Chemotactic factor inactivator in normal human serum.
Berenberg JL, Ward PA. Berenberg JL, et al. J Clin Invest. 1973 May;52(5):1200-6. doi: 10.1172/jci107287. J Clin Invest. 1973. PMID: 4121701 Free PMC article. - Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.
Vallota EH, Forristal J, Spitzer RE, Davis NC, West CD. Vallota EH, et al. J Exp Med. 1970 Jun 1;131(6):1306-24. doi: 10.1084/jem.131.6.1306. J Exp Med. 1970. PMID: 4192571 Free PMC article. - Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.
Hedberg H, Lundh B, Laurell AB. Hedberg H, et al. Clin Exp Immunol. 1970 May;6(5):707-12. Clin Exp Immunol. 1970. PMID: 5477926 Free PMC article.
References
- J Immunol. 1964 Dec;93:972-84 - PubMed
- J Immunol. 1965 Jun;94:877-82 - PubMed
- J Exp Med. 1965 Aug 1;122:277-98 - PubMed
- J Exp Med. 1963 Sep 1;118:447-66 - PubMed
- J Exp Med. 1960 Feb 1;111:201-15 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous